Phase 2 Study of Indomethacin Capsules to Treat Dental Pain

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.

Official Title
-----------------
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars

Conditions
-----------------
Dental Pain

Intervention / Treatment
-----------------
* Drug: Celecoxib 400 mg
* Drug: Placebo
* Drug: Indomethacin Test (lower dose)
* Drug: Indomethacin Test (upper dose)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient is male or female between 18 and 50 years of age For women of child-bearing potential: a woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control Patient requires extraction of 2 or more third molars Patient must be willing to stay at the study site for at least 8 hours after dosing of the study drug Exclusion Criteria: Patient has hypersensitivity, allergy, or clinically significant intolerance to any medications to be used in the study, or related drugs Patient has a current disease or history of a disease that will impact the study or the patient's well-being Patient has used or intends to use any of the medications that are prohibited by the protocol Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen or alcohol breathalyzer test Patient has taken another investigational drug within 30 days prior to Screening

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 50 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Indomethacin Test (lower dose)<br> | Drug: Indomethacin Test (lower dose)<br>* 20-mg single dose<br>|
| Experimental: Indomethacin Test (upper dose)<br>Single dose | Drug: Indomethacin Test (upper dose)<br>* 40-mg single dose<br>|
| Active Comparator: Celecoxib 400 mg<br> | Drug: Celecoxib 400 mg<br>* Capsules 2 x 200 mg Single-Dose<br>|
| Placebo Comparator: Placebo<br> | Drug: Placebo<br>* Capsules 2 Single-Dose<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Total Patient Pain Relief Over 0 to 8 Hours. | Total patient pain relief was assessed as a time-weighted sum of the patient pain assessments at each individual time point from 0-8 hours. Values for TOTPAR are measured from 0 to 4 on the Pain Relief Scale 0 None Min; 1 A little; 2 Some; 3 A lot; 4 Complete Max The TOTPAR is a weighted measure of the observations; the minimum possible value is 0 and the maximum possible value is 32. | 8 hours |